We further demonstrate the binding of Smad4 and Ets-1 to the genomic region of exon12 of FPGS in AML patient blasts exhibiting low FPGS expression, while no such binding was detected in an AML patient specimen with high FPGS levels. Here, SMAD4 is linked to acute myeloid leukemia.